WHO ICTRP trial
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of…
EUCTR2010-020398-18-FI · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-020398-18-FI |
|---|---|
| Public title | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Metastatic Adenocarcinoma of the Pancreas - GAMMA |
| Scientific title | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Metastatic Adenocarcinoma of the Pancreas - GAMMA |
| Primary sponsor | Amgen Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal;Slovenia;Greece;Finland;Spain;Lithuania;Austria;Italy;United Kingdom;Hungary;Czech Republic;Belgium;Denmark;Netherlands;Germany;Sweden |
| Conditions | metastatic adenocarcinoma of the pancreas MedDRA version: 12.1 Level: LLT Classification code 10033605 Term: Pancreatic cancer metastatic MedDRA version: 12.1 Level: LLT Classification code 10033606 Term: Pancreatic cancer non-resectable |
| Interventions | Product Name: AMG 479 Product Code: AMG 479 Pharmaceutical Form: Concentrate for solution for infusion Current Sponsor code: AMG 479 Concentration unit: mg/l milligram(s)/litre Concentration type: up to Concentration number: 20… |
| Registration date | Nov 17, 2010 |
| Target size | 825 |
| Secondary IDs | 20060540 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: